Study Evaluating Approach to Treatment of Haemophilia A and B in Spain - Full Text View

Sponsored by:	Wyeth
Information provided by:	Wyeth
ClinicalTrials.gov Identifier:	NCT00581438

Purpose

Analyze the clinical and therapeutic approach to treatment of haemophilia A and B in habitual clinical practice conditions in Spain.

Condition
Hemophilia A Hemophilia B

Genetics Home Reference related topics: hemophilia L1 syndrome

MedlinePlus related topics: Hemophilia

U.S. FDA Resources

Study Type:	Observational
Study Design:	Case-Only, Retrospective
Official Title:	Actual Approach to Treatment of Haemophilia A and B in Spain

Further study details as provided by Wyeth:

Primary Outcome Measures:

Analyze the clinical and therapeutic approach to treament of haemophilia A and B in habitual clinical practice conditions in Spain during the first 3 years since diagnosis. [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Assess haemophilia A or B patient profile, study different kinds of habitual clinical treatment of haemophilia A and B patients, and estimate the dosage units used per year in patients under habitual clinical practice conditions. [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Enrollment:	52
Study Start Date:	June 2007
Study Completion Date:	December 2007
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)

Groups/Cohorts
1

Detailed Description:

Analyze the clinical and therapeutic approach to treatment of haemophilia A and B in habitual clinical practice conditions in Spain during the first 3 years since diagnosis.

Assess haemophilia A or B patient profile, study different kinds of hanitual clinical treatment of haemophilia A and B patients, and estimate the kind of treatment and dosage units used per year in patients under habitual clinical practice conditions.

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

People known to have Haemophilia A or B

Criteria

Inclusion Criteria:

Haemophilia A or B patients of any age
Written informed consent

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00581438

Sponsors and Collaborators

Wyeth

Investigators

Study Director:

Medical Monitor

Wyeth

More Information

Responsible Party:	Wyeth ( Wyeth (Registry Contact: Clinical Trial Registry Specialist) )
Study ID Numbers:	3082A-102378
Study First Received:	December 21, 2007
Last Updated:	December 26, 2007
ClinicalTrials.gov Identifier:	NCT00581438
Health Authority:	Spain: Ministry of Health; Spain: Ministry of Health and Consumption; Spain: Spanish Agency of Medicines

Keywords provided by Wyeth:

Approach Haemophilia A and B

Study placed in the following topic categories:

Hemophilia B
Hemorrhagic Disorders
Genetic Diseases, Inborn
Hematologic Diseases

Blood Coagulation Disorders
Hemophilia A
Genetic Diseases, X-Linked
Hemostatic Disorders

Additional relevant MeSH terms:

Blood Coagulation Disorders, Inherited
Coagulation Protein Disorders

ClinicalTrials.gov processed this record on January 13, 2009